Treatment News : Making It Official: HIV Meds Have Improved Vastly

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » July 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 18, 2013

Making It Official: HIV Meds Have Improved Vastly

During the history of HIV, clinical trials of antiretrovirals (ARVs) have charted a steady, upward climb in efficacy, according to a large meta-analysis, MedPage Today reports. Researchers culled together findings from all reported prospective trials of ARVs in treatment-naive people with HIV that had at least 48 weeks of follow-up and an intent-to-treat efficacy analysis. This included 144 studies among 216 treatment groups, including 10 trials dating from before the 1996 treatment revolution. The investigators reported their findings at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.

The proportion of study participants that reached an undetectable viral load was about 47 percent before 2000, compared with 82 percent of those from after 2008. Those ARV regimens that the U.S. Department of Health and Human Services guidelines panel have designated as “preferred” boasted superior efficacy to the panel’s “alternative” regimens, which themselves outperformed other drug combinations.

To read the conference abstract, click here.

To read the MedPage Today article, click here.

Search: HIV, antiretrovirals, MedPage Today, prospective trials, improved efficacy, 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, IAS 2013.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    andais
    Red House
    West Virginia


    Sloan1
    Dallas
    Texas


    Fred9774
    Brooklyn
    New York


    RayOctober
    Richmond
    Virginia
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.